COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: www.coronavirus.gov
Get the latest grant and research information from NIH: www.nih.gov/coronavirus

NIH staff guidance on coronavirus (NIH Only): https://employees.nih.gov/pages/coronavirus

Clinical Research Section

of the Liver Diseases Branch

T. Jake Liang, M.D., NIH Distinguished Investigator

Section Chief

jake.liang@nih.gov

A group of physician-scientists investigating the pathogenesis, natural history, and novel therapeutics for a wide range of liver diseases.

About Our Research

Select Publications

Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly.: Li Q, Pène V, Krishnamurthy S, Cha H, Liang TJ.; Nat Med (2013 Jun) 19:722-9. Abstract/Full Text
Current and future therapies for hepatitis C virus infection.: Liang TJ, Ghany MG.; N Engl J Med (2013 May 16) 368:1907-17. Abstract/Full Text

View More Publications

Lab Members

Photo of the Clinical Research Section staff.

View Our Lab Members

Clinical Trials Research Materials